Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
Derek Rose

CSL, Mayne Pharma expect to dodge new US pharma tariffs

CSL believes its operations in the US will shield it from the Trump administration's new tariffs. (James Ross/AAP PHOTOS)

Australian blood products and vaccine giant CSL doesn't expect to be impacted by new US pharmaceutical tariffs, and neither does two smaller ASX-listed drug companies.

CSL said on Tuesday it was still working through details of US President Donald Trump's tariff proclamation, but its initial view was most of its US product sales wouldn't be subject to tariffs.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.